Cited by 22Metabolism, Diabetes, and CancerGlycogen Storage Diseases and MyoclonusDiabetes, Cardiovascular Risks, and Lipoproteins

Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity

Open access
Lehto, M., Huang, X., Davis, E. M., Le Beau, M. M., Laurila, E., Eriksson, K. F., Bell, G. I., Groop, L.·1995·Diabetologia

Abstract

In muscle, hexokinase II (HK2) regulates phosphorylation of glucose to glucose 6-phosphate, which has been reported to be impaired in patients with non-insulin-dependent diabetes mellitus (NIDDM). Here we report decreased HK2 enzyme activity in skeletal muscle biopsies from patients with impaired glucose tolerance compared with healthy control subjects (2.7 +/- 0.9 vs 4.9 +/- 1.1 nmol.min-1.mg protein-1). Therefore, mutations in the HK2 gene could contribute to skeletal muscle insulin resistance in NIDDM. To address this question, we first determined the exon-intron structure of the human HK2 gene and using this information, we screened all 18 exons with single-strand conformation polymorphism technique in 80 Finnish NIDDM patients. Nine nucleotide substitutions were found, one of which was a missense mutation (Gln142-His142) in exon 4. In human muscle, a single HK2 mRNA transcript with a size of approximately 5500 nucleotides was detected with Northern blot analysis. We also describe an HK2 pseudogene (HK2P1), which was mapped to chromosome 4, band q26, by fluorescence in situ hybridization to metaphase chromosomes. The clinical characteristics and HK2 enzyme activities of the subjects with either Gln or His at residue 142 did not differ from each other. Instead, HK2 activity correlated inversely with fasting blood glucose levels, suggesting that changes in HK2 activity could be secondary to other metabolic abnormalities (r = 0.55; p < 0.0003; n = 39). In conclusion; the data suggest that impaired HK2 activity in prediabetic individuals is a consequence of impaired glucose tolerance rather than of a genetic abnormality. The data thus seem to rule out mutations in the HK2 gene as a major cause of inherited insulin resistance in NIDDM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00400608

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Point mutations in the HK-II gene found in type 2 diabetes are not close to glucose and ATP binding sites and are not associated with insulin resistance.

    “Several groups have looked for point mutations in the HK-II gene in individuals with type 2 diabetes, and, although several nucleotide substitutions have been found, none are close to the glucose and ATP binding sites and none have been associated with insulin resistance [203–205].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [203]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lehto, M., Huang, X., Davis, E. M., Le Beau, M. M., Laurila, E., Eriksson, K. F., Bell, G. I., & Groop, L.
Affiliations
  • University of Helsinki (FI)
  • University of Chicago (US)
  • Howard Hughes Medical Institute (US)
Venue
Diabetologia
Published
1995-12
Volume
38
Issue
12
Pages
1466-1474
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2001074090
Cited by
22
References
25
Citations by year
2022: 1 · 2021: 1 · 2018: 2 · 2017: 1 · 2015: 1 · 2012: 1
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • U.S. Public Health Service (DK-20595)
  • Medical Research Council
  • National Cancer Institute (P01CA040046, CA-40046)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 20595)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
hexokinase 2, exon-intron organization, type 2 diabetes, impaired glucose tolerance, skeletal muscle insulin resistance, missense mutations, fasting blood glucose, glucose phosphorylation
MeSH terms
Aged, Base Sequence, Diabetes Mellitus, Type 2, DNA Mutational Analysis, Exons, Female, Hexokinase, Humans, Insulin Resistance, Introns, Isoenzymes, Male, Middle Aged, Molecular Sequence Data, Mutation, Polymorphism, Genetic, Pseudogenes, Restriction Mapping, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, DNA Primers, Muscle, Skeletal, Polymorphism, Single-Stranded Conformational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review